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Abstract                      
Introduction: Resistance of pathogenic organisms to countenance antibiotics has become a 
worldwide problem with serious consequences on the treatment of infectious diseases. The aim 
of this study was to evaluate antibiotic resistance and also the detection of transferred antibiotic 
resistance by plasmid in clinical Proteus isolates. 
Materials and methods: A total of 250 urine samples were collected from patient suffered 
from urinary tract infection (UTI), and cultured on blood agar and MacConkey's agar. Positive 
cultures were diagnosed by routine microbiological and biochemical tests. Antibiotic 
susceptibility test was performed by disc diffusion method. The minimum inhibitory 
concentration (MIC) was evaluated by agar dilution method, and also antibiotic resistance 
mediated by plasmid was determined using transformation of plasmids to plasmid free 
Escherichia coli ATCC 25922 as competent cell. 
Results: Among 200 samples, 120 samples (60%) were collected from female and 80 samples 
(40%) were isolated from males. Out of 25 species (12.5%) were diagnosed as Proteus. Al 
isolates were resistant to ampicillin (maximum frequency), only 16% of isolates were 
resistance to amikacin (minimum resistance). Totally, 66.66% of Proteus isolates harbored 
plasmids. All plasmid containing P. mirabilis isolates were able to transferred resistance to 
amoxicillin, ampicillin, while rate of resistance to other antibiotics were as amikacin (88%), 
gentamycin (72%), tetracycline (50%), tobramycin (48%), ceftazidime, cefotaxime (32%) and 
ciprofloxacin (22%). 
Conclusion: Widespread use of antibiotics cause to spread or emerge antibiotic resistances 
among bacteria by R–plasmids transfer.  
Keywords: Proteus, Urinary tract infections, Antibiotic resistance, Plasmid transformation 
Introduction 
Proteus, gram-negative bacilli that thrive in 
soil, water and the intestinal tracts of 
mammals, is capable of swarming or 
swimming in a coordinated manner, on 
solid surfaces. Several species of Proteus 
species are known to colonize and infect the 
human host, but, the one most frequently 
linked with causing human disease is 
Proteus mirabilis. These bacteria are the 
causative agents of a variety of 
opportunistic nosocomial infections 
including those of the respiratory tract, eye, 
ear, nose, skin, burns, throat and wounds 
(1). Proteus mirabilis is more commonly 
associated with urinary tract infection, 
individual with structural or functional 
abnormalities, especially ascending 
infections in patients undergoing urinary 
catheterization (2). Proteus species are 
among the commonly implicated pathogens 
in hospital as well as community acquired 
infections (3).Strains are intrinsically 
resistant to bacitracin, colisitin and 
polymyxin and are generally susceptible to 
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nalidixicacid and penicillin. However, 
resistance to these antibiotics and or others 
are currently reported at increasing 
frequency; a phenomenon which usually 
results in difficult treatment and control of 
P. mirabilis infections (4). Mechanisms of 
resistance of P. mirabilis are plasmid and 
chromosomal–mediated. There are many 
mechanisms were by bacteria confer 
resistance to the drugs including intrinsic 
impermeability and acquired resistance as 
plasmids, transposons and mutations (5). 
Transferable resistance has been identified 
for some antibiotic groups as β-lactams, 
aminoglycosides, macrolides, 
sulphonamides, tetracycline, 
chloramphenicol, etc. (6).This study aimed 
to determine of susceptibility patterns and 
the evaluation of phenotyping and 
molecular (plasmid transfer) resistance to 
antibiotics in Proteus isolated from urinary 
tract infection in Ilam 
 
Materials and methods 
 
Sample collection: A total of 200 primary 
culture positive samples which were 
collected from hospitalized cases of UTI of 
two hospitals from Ilam. All samples were 
transported to clinical microbiology 
research in Ilam university and were stored 
frozen at -80C in Skim Milk broth, 
containing 10% glycerol (7).  
Diagnosis of isolates: The samples were 
collected in a one year period from 
September 2012 to September 2013. 
Specimens were screened by Gram's stain 
and were cultured on 10% sheep blood agar 
and MacConkey's agar. All isolates were 
identified by catalase production, 
haemolysis on blood agar, oxidative-
fermentative test, motility, Methyl red 
(MR) test, Vogex-Proskauer test (VP), 
citrate utilization test, triple sugar iron 
(TSI), produced H2S, production of bound 
and free coagulase, mannitol fermentation 
and 7.5 percent NaCl tolerance and heat 
labile DNase, protease on skim milk, 
amylase, protease on gelatin, urease, nitrate 
reductase, and indole production (8). 
Antibiotics susceptibility test: Antibiotic 
susceptibility test was performed by Kirby 
Bauer disc diffusion method on Mueller-
Hinton agar and minimum inhibitory 
concentrations(MICs) of all antibiotics 
were determined by agar dilution methods 
according to Clinical and Laboratory 
Standards Institute recommendations 
(CLSI, 2007). The following antibiotics 
were tested: Ampicillin (10μg), Co-
trimoxazole (25μg), Gentamycin (10μg), 
Ciprofloxacin (10μg), Cefotaxime (30μg), 
ceftazidime (30μg), tetracycline (30μg), 
tobramycin (10μg), Amoxicillin (10μg), 
Amikacin (30μg) (Biorad, Marnes-la-
coquette, France). The diameter of zone of 
growth-inhibition observed was measured 
and compared according to 
recommendations of CLSI guidelines. E. 
coli ATCC 25922 was used as negative 
control (10).  
Plasmid DNA extraction: All proteus 
isolates were selected for plasmid 
extraction and determination of plasmid 
mediated resistant. Briefly a fresh colony of 
all proteus isolates were cultured in LB 
medium and incubated at 37ᵒC overnight 
and their turbidity adjusted to 0.5 
McFarland standards, and 1ml of each 
isolates were cultured in 5ml tubes 
containing LB medium and incubated 
overnight at 37ᵒC for plasmid isolation. 
Plasmid DNA extraction and purification 
was carried out using YTA Miniprep Kit 
(Yekta Tajhiz Azma Co, Tehran, Iran), 
according to the manufacturer’s 
instructions . 
Agarose gel electrophoresis: The purity of 
plasmid was evaluated at 260 nm by 
spectrophotometery. The plasmid DNA 
was observed by gel electrophoresis. To 
prepare the gel, Agarose gel powder (0.8%) 
was dissolved in TAE buffer (40 Mm Tris-
Hcl, 50 mM Sodium acetate, 1 Mm EDTA; 
pH 8). The extracted DNA was added to the 
gel and the Gel was run for two and half 
hours at 50 V, stained for 30 min with 
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plasmids were visualized under UV light in 
Alpha imager gel documentation system 
(Syngene, UK). 
Preparation of competent cells: A fresh 
colony of E.coli ATCC 25922 was cultured 
in 5 ml LB broth and incubated at 37°C 
overnight in shaker incubator at round 
250rpm, Then inoculate 5ml of overnight 
culture into a flasks containing 500 ml L 
broth, and incubated at 37°C with aeration 
until the culture reaches OD550 of 0.5 
(approximately 5 x 107cells/ml) 
Transferred cells to centrifuge bottles and 
spin in Sorvall GSA rotor at 4°C for 8 min 
at 8000rpm. The supernatant discarded and 
gently resuspended pellets in 250 ml ice 
cold 0.1 M CaCl2 and combined into a 
single bottle, then spine 8 min at 8000 rpm 
in GSA rotor, supernatant discarded again 
and pellet resuspended in 250 ml ice cold 
0.1 M CaCl2 and stored on ice for 6 hours, 
then centrifuged at 8000 rpm for 8 min at 
4°C. Resuspended pellet in 43 ml of ice 
cold 0.1 M CaCl2 with 7 ml sterile glycerol. 
At last distributed suspension of competent 
cells into convenient aliquots (0.2 ml) in 
cold Eppendorf tubes and Frozen and store 
at -70°C (11). 
Plasmid transformation: 50ng of plasmid 
consortium was added to 300μl of thawed 
competent cells E.coli ATCC 25922 in ice. 
The suspension immediately placed on ice 
for 30 minutes and then tubes were placed 
in 42°C water bath for 2 min (heat 
shock).The mixtures were transferred to 
1mm LB medium, and incubated at 37°C 
with shaking, for 1 hour.Then streaked out 
50µl of transformed cells onto LB agar 
plates containing ampicillin antibiotic and 
incubated at 37ᵒC for 24hours (11). In this 
section digested DNA was used as negative 
control . 
Resistance pattern of transformed cells: 
Resistance patterns were determined by the 
disc diffusion test methodology, with discs 
containing 10 different antimicrobial agents 
as : ampicillin (10μg), co-trimoxazole 
(25μg), gentamycin (10μg), ciprofloxacin 
(10μg), cefotaxime (30μg), ceftazidime 
(30μg), tetracycline (30μg), tobramycin 
(10μg), amoxicillin (10μg), amikacin 
(30μg), and E.coli ATCC 25922 was used 
as negative control (10). 
Statistical analysis 
For the statistical analyses, the statistical 
software SPSS version 18 for Windows 
(SPSS Inc., Chicago, IL) was uti¬lized. 
Continuous variables were described as 
mean ± standard deviation (SD) and 
compared with standard student t test, or 
and calculates median range. All the tests 
were two-tailed and P < 0.05 was 
considered statistically significant (9). 
Results 
Identification of isolates: In this study, 
totally 200 samples were collected from 
patients; those were primary positive 
culture by urine culture. The most common 
isolate was E.coli 85(42.5%), followed by 
Proteus species 25(12.5%), Pseudomonas 
species 21(10.5%), Klebsiella species 
20(10%), Citrobacter species 18(9%),   
Staphylococcus aureus 12 (6%), 
Entrobacter species 11(5.5%), coagulase-
negative staphylococcus 5 (2.5%), and 
Providencia 3(1.5%). Out of 120 samples, 
(60%) were taken from females and 80(40 
%) from male patients (Figure1). 
Differential and serological test results 
showed that of the 25 Proteus isolated, 18 
strains (72%) were Proteus mirabilis, 
followed by Proteus vulgaris 6 strains 
(24%)  and 1 strain (4%) Proteus rettgeri 
were identified. 
Antibiotic susceptibility profiles and 
distribution of MICs of different 
antibiotics: Table1 shows the antibiotic 
resistant pattern of Proteus isolates to 10 
antibiotics, the isolates showed high 
frequency of antibiotic resistance against 
ampicillin (100%) and low frequency of 
antibiotic resistance against amikacin with 
(16%). The patterns of MICs of 10 
antibiotics on the Proteus isolates were 
determined with concentrations varying 
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Table1.  Antibiotic resistant pattern and MIC pattern of Proteus isolates. 
Antibiotic TS TOB GN AK CIP TE CTX CAZ AMX AMP 
Proteus 56 48 52 16 32 80 40 48 80 100 
MIC(µg/ml) ˃32 32 ˃32 64 32 ˃64 32 ˃32 ˃64 128 
AMP: Ampicillin, AMX: Amoxicillin, CAZ: Ceftazidime, CTX: Cephotaxime, TE: Tetracycline, CIP: 
Ciprofloxacin, AK: Amikacin, GN: Gentamycin, TOB: Tobramycin, TS: Co-trimoxazole. 
Resistant pattern conferred by plasmid 
to E.coli ATCC 25922: Results of 
transformant isolates showed that, more 
than of 66.6% of proteus isolates harbored 
one or more than one transformable 
plasmid, and resistant to ampicillin, 
amoxicillin, gentamycin, ciprofloxacin, 
cefotaxime and ceftazidime transformed in 
all isolates (100%) due to presence of 
plasmid. The resistance to amikacin, 
tobramycin and tetracycline was transferred 
in 88%, 48% and 66.6% of isolates due to 
presence of plasmids with molecular weight 
range of 4.8kb, 5.2 Kb and higher than it 
(Figures 1 and 2). 
 
 
Figure 1. Electrophoresis of plasmid DNA isolated from Proteus isolates. M: DNA ladder, Con- : negative control 





Figure 2.  Plasmid transformation to the competent E.coli ATCC 25922. A: Transformed colonies (competent 
E.coli ATCC 25922) in the Luria-Bertani Agar (LBA) medium complemented by antibiotic ampicillin. B: 
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In the present study, out of 200 samples 
were studied, and 25 (12.5%) of Proteus 
bacteria were isolated from patients 
suffered from urinary tract infection and 
66.6% of these isolates were consist of 
plasmid that mediated antibiotic resistant 
.In a study conducted by Orhue, O.Phillips 
(2014) in Nigeria, among all bacteria 
isolated from patients with urinary tract 
infection, Proteus strains were known as the 
causes of 14.5% of these infections and 
antimicrobial susceptibility pattern of this 
study was similar to our data, however they 
did not perform molecular analysis of these 
strains (12). In other study performed by 
Okesola AO, and Adeniji TW (2010), they 
evaluated 50 different clinical Proteus 
isolates, that, their antibiogram profile is in 
agreement with our study (13).Chaudhary 
NK and Morthys SM (2015) , in India 
reported that, Staphylococcus aureus those, 
causes urinary tract infection acquired 
resistant to methicillin and vancomycin via 
plasmid (14). Adeniyi BA (2006), showed 
that the rate of resistance to ampicillin, co-
trimoxazole, gentamycin, ciprofloxacin and 
tetracycline were 94.2%, 84%, 84.6%, 
50%, and 100%, respectively . The result of 
this study is in agreement with our data 
(15), Only 9 out of 18 (50%) of P. mirabilis 
isolates were harbored plasmids. In the 
present study, 66.6%(6 isolates) of plasmid-
containing P. mirabilis isolates were able to 
transfer antibiotic resistance to the standard 
E.coli ATCC 25922 which is in agreement 
with the results from Makled et al, and 
Bonnet et al (16,17). The resistant to 
amoxicillin, ampicillin, gentamycin, 
tobramycin, amikacin, co-trimoxazole, 
cefotaxime, ceftazidime ciprofloxacin and 
tetracycline was transferred in 100% of 
isolates due to presence of plasmids with 
molecular weight 180, 170 and 25 Kb, 
which is in disagreement with the results of 
this study (18). Neuwirth et al, (2001), 
reported that resistance to β–lactams was 
cotransferred with resistance to 
aminoglycosides (amikacin, Kanamycin 
and tobramycin), sulphonamides and 
chloramphenicol (19). In conclusion, 
indiscriminate use of antibiotics has led to 
selection of resistant strain with R–
plasmids transferable between enteric 
bacteria by transformation and this resistant 
bacterium may disseminate among 
individuals. According to this study it’s 
necessary to determine the antibiotic 
susceptibility and plasmid profiles of 
Proteus mirabilis isolated from urinary tract 
infections in order to provide proper 
treatment, this will prevent their 
dissemination and reduce the risk of urinary 
tract infection complication. 
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